bbd23e87bdbc50a9ee58c32982ff7987cb943af6
lrnassar
  Tue Sep 3 08:58:25 2024 -0700
Removing these tracks from internal trackDb since they are to be released only as public hubs refs #34352

diff --git src/hg/makeDb/trackDb/human/enigma.html src/hg/makeDb/trackDb/human/enigma.html
deleted file mode 100644
index e8d65a8..0000000
--- src/hg/makeDb/trackDb/human/enigma.html
+++ /dev/null
@@ -1,145 +0,0 @@
-<H2>Description</H2>
-<p>
-
-<div class="warn-note" style="border: 2px solid #9e5900; padding: 5px 20px; background-color: #ffe9cc;">
-<p><span style="font-weight: bold; color: #c70000;">NOTE:</span><br>
-<b>These data are for research purposes only. While the ClinGen data are 
-open to the public, users seeking information about a personal medical or 
-genetic condition are urged to consult with a qualified physician for 
-diagnosis and for answers to personal medical questions.
-</p>
-<p> 
-UCSC presents these data for use by qualified professionals, and even 
-such professionals should use caution in interpreting the significance of 
-information found here. No single data point should be taken at face 
-value and such data should always be used in conjunction with as much 
-corroborating data as possible. No treatment protocols should be 
-developed or patient advice given on the basis of these data without 
-careful consideration of all possible sources of information.
-</p>
-<p> 
-No attempt to identify individual patients should 
-be undertaken. No one is authorized to attempt to identify patients 
-by any means.
-</p> 
-</b>
-</div>
-
-<p>
-The tracks listed here contain data from the ClinGen ENIGMA BRCA1 and BRCA2 
-Expert Panel Specifications to the ACMG/AMP Variant Interpretation 
-Guidelines for BRCA1/BRCA1 Version 1.0.0. The ENIGMA VCEP has adapted 
-the ACMG-AMP codes for the BRCA1 and BRCA2 genes. These include the 
-codes PVS1 (modified PVS1 decision tree), PS3/BS3 (functional data), 
-PP4/BP5 (multifactorial data), PM5_PTC (PTC data, at exon level), 
-the (potentially) clinically important functional domains defined by 
-ENIGMA, and prediction programs (SpliceAI and BayesDel for PP3/BP4).<br><br>
-The data required for the application of these ENIGMA codes are displayed in 5 data tracks:</p>
-<p>
-<ul>
-<li><b>BRCA1/BRCA2 protein domains 1.1.0</b> -
-Shows the (potentially) clinically important functional domains for 
-the genes BRCA1 and BRCA2 as defined by ENIGMA. Data taken from Figure 
-1 of the guidelines document CSpec_BRCA12ACMG-Rules-Specifications_V1.0_23-04-27.
-</li>
-<li><b>BRCA1/BRCA2 exon weights 1.1.0</b> -
-This track shows exon-specific weights for the PM5_PTC ACMG code and is used 
-for the application of novel protein termination codon (PTC) 
-variants in an exon where a different proven pathogenic PTC variant 
-has been seen before. Data taken from guidelines document 
-CSpec_BRCA12ACMG_Rules-SupplementaryTables_V1.0_23-04-27.
-</li>
-<li><b>BRCA1/BRCA2 functional assays 1.1.0</b> -
-Summary of BRCA1 and BRCA2 functional assay results reviewed for 
-application of PS3 and BS3 ACMG codes. Data taken from guidelines 
-document CSpec_BRCA12ACMG-Rules-Specifications_V1.0_Table-9_23-04-27.
-</li>
-<li><b>BRCA1/BRCA2 splicing 1.1.0</b> -
-Summary of ACMG codes applicable for variants considered against 
-the BRCA1 and BRCA2 PVS1 decision trees. Includes PVS1 and PM5 
-codes recommended for initiation, nonsense/frameshift, deletion, 
-duplication, and splice site (donor/acceptor ±1,2) variants– 
-organized by exon. Data taken from guidelines document 
-CSpec_BRCA12ACMG-Rules-Specifications_V1.0_Table-4_23-04-27.
-</li>
-<li><b>BRCA1/BRCA2 likelihood for PP4 and BP5</b> -
-Summary of BRCA1 and BRCA2 multifactorial likelihood analysis 
-scores (displayed as Combined LR score) for ACMG codes PP4 and BP5. 
-Data taken from Parsons et al. 2019 suppl table HUMU-40-1557-s001_Parson_Multicatorial.xlsx.
-</li>
-</ul>
-</p>
- 
-<h2>Display Conventions</h2>
-<p>
-<ul>
-<li><b>BRCA1/BRCA2 protein domains 1.1.0</b> -
-Items in <b><font color="red">red</font></b> show clinically relevant 
-protein domains. Mouseover on items shows the name of the domain and the location.
-</li>
-<li><b>BRCA1/BRCA2 exon weights 1.1.0</b> -
-Mouseover on exons (black items) shows the transcript, exon number, and the PM5_PTC code strength.
-</li>
-<li><b>BRCA1/BRCA2 functional assays 1.1.0</b> -
-Variants assigned with BS3 code are displayed in <b><font color="green">green</font></b>, 
-PS3 code in <b><font color="red">red</font></b>, or no code assigned in black. 
-Mouseover on items show variant HGVS nomenclature, assigned ACMG code and code weight.
-</li>
-<li><b>BRCA1/BRCA2 splicing 1.1.0</b> -
-Items show variant positions, <b><font color="red">red</font></b> indicates 
-exon deletions, <b><font color="blue">blue</font></b> exon duplications, and purple 
-items indicate variants with supporting RNA-based functional evidence. Mouseover 
-on items show transcript, exon, variant position, possible variant type at 
-that position, and assigned ACMG code to the variant.
-</li>
-<li><b>BRCA1/BRCA2 likelihood for PP4 and BP5</b> -
-Variants assigned with PP4 code are displayed in <b><font color="red">red</font></b>, BP5 code 
-in <b><font color="green">green</font></b>, and non-informative variants (no code 
-assigned) in grey. Mouseover on items show variant HGVS nomenclature, combined 
-likelihood ratio (LR) score, and assigned ACMG code and strength.
-</li>
-</ul>
-</p>
-
-<h2>Data Access</h2>
-<p>
-The most up-to-date VCEP specifications for the application of ACMG/AMP criteria 
-for BRCA1 and BRCA2 genes are freely available at the <a target="_blank" 
-href="https://cspec.genome.network/cspec/ui/svi/affiliation/50087">ClinGen 
-Criteria Specification (CSpec) Registry</a>. This registry is intended to 
-provide access to the Criteria Specifications used and applied by <a 
-target="_blank" href="https://clinicalgenome.org/affiliation/vcep/#ep_table_heading">ClinGen 
-Variant Curation Expert Panels</a> and biocurators in the classification of variants.
-</p>
-
-<h2>Methods</h2>
-<p>
-These data were created and adapted from the files referenced above. Some custom 
-scripting was employed in tasks like mapping variants, adding colors and 
-mouseovers, and producing the desired format. For the complete details on 
-the data processing see the makedoc on our <a target="_blank" 
-href="https://github.com/ucscGenomeBrowser/kent/blob/master/src/hg/makeDb/doc/enigma.txt">github</a>.
-</p>
-
-<h2>Credits</h2>
-<p>
-Thank you to Luis Nassar from the Genome Browser team, Anna Benet-Pagès 
-and Andreas Laner for technical coordination and consultation, and to 
-the ENIGMA consortia for making these data available.</p>
-
-<h2>References</h2>
-
-<p>
-Enigma Guidelines: <a target="_blank" href="https://clinicalgenome.org/affiliation/50087/">https://clinicalgenome.org/affiliation/50087/</a></p>
-<p>
-Enigma Consortium: <a target="_blank" href="https://enigmaconsortium.org/">https://enigmaconsortium.org/</a></p>
-<p>
-Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadal&#243; L, Aalfs CM, Agata S,
-Aittom&#228;ki K, Alducci E <em>et al</em>.
-<a href="https://doi.org/10.1002/humu.23818" target="_blank">
-Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA
-resource to support clinical variant classification</a>.
-<em>Hum Mutat</em>. 2019 Sep;40(9):1557-1578.
-PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/31131967" target="_blank">31131967</a>; PMC: <a
-href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772163/" target="_blank">PMC6772163</a>
-</p>